These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8470355)

  • 1. Red cell and plasma concentrations of fluoxetine and norfluoxetine.
    Amitai Y; Kennedy E; DeSandre P; Fawcett J; Frischer H
    Vet Hum Toxicol; 1993 Apr; 35(2):134-6. PubMed ID: 8470355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ratio of plasma fluoxetine to norfluoxetine concentrations and associated sedation.
    Keck PE; McElroy SL
    J Clin Psychiatry; 1992 Apr; 53(4):127-9. PubMed ID: 1564047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution and excretion of fluoxetine and norfluoxetine in human milk.
    Kristensen JH; Ilett KF; Hackett LP; Yapp P; Paech M; Begg EJ
    Br J Clin Pharmacol; 1999 Oct; 48(4):521-7. PubMed ID: 10583022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postmortem serum and tissue redistribution of fluoxetine and norfluoxetine in dogs following oral administration of fluoxetine hydrochloride (Prozac).
    Pohland RC; Bernhard NR
    J Forensic Sci; 1997 Sep; 42(5):812-6. PubMed ID: 9304827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoxetine and norfluoxetine plasma concentrations in major depression: a multicenter study.
    Amsterdam JD; Fawcett J; Quitkin FM; Reimherr FW; Rosenbaum JF; Michelson D; Hornig-Rohan M; Beasley CM
    Am J Psychiatry; 1997 Jul; 154(7):963-9. PubMed ID: 9210747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of the antidepressant fluoxetine and its metabolite norfluoxetine in serum by reversed-phase HPLC with ultraviolet detection.
    Orsulak PJ; Kenney JT; Debus JR; Crowley G; Wittman PD
    Clin Chem; 1988 Sep; 34(9):1875-8. PubMed ID: 3262022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of fluoxetine and norfluoxetine in human plasma by high-performance liquid chromatography with ultraviolet detection in psychiatric patients.
    LLerena A; Dorado P; Berecz R; González A; Jesús Norberto M; de la Rubia A; Cáceres M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jan; 783(1):25-31. PubMed ID: 12450521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma concentrations of the enantiomers of fluoxetine and norfluoxetine: sources of variability and preliminary observations on relations with clinical response.
    Jannuzzi G; Gatti G; Magni P; Spina E; Pacifici R; Zuccaro P; Torta R; Guarneri L; Perucca E
    Ther Drug Monit; 2002 Oct; 24(5):616-27. PubMed ID: 12352933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between antidepressant response and plasma concentrations of fluoxetine and norfluoxetine.
    Norman TR; Gupta RK; Burrows GD; Parker G; Judd FK
    Int Clin Psychopharmacol; 1993; 8(1):25-9. PubMed ID: 8473717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous determination of plasma levels of fluvoxamine and of the enantiomers of fluoxetine and norfluoxetine by gas chromatography-mass spectrometry.
    Eap CB; Gaillard N; Powell K; Baumann P
    J Chromatogr B Biomed Appl; 1996 Jul; 682(2):265-72. PubMed ID: 8844419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of CYP2D6 and CYP2C9 genotypes on fluoxetine and norfluoxetine plasma concentrations during steady-state conditions.
    LLerena A; Dorado P; Berecz R; González AP; Peñas-LLedó EM
    Eur J Clin Pharmacol; 2004 Feb; 59(12):869-73. PubMed ID: 14726986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereoselective disposition of fluoxetine and norfluoxetine during pregnancy and breast-feeding.
    Kim J; Riggs KW; Misri S; Kent N; Oberlander TF; Grunau RE; Fitzgerald C; Rurak DW
    Br J Clin Pharmacol; 2006 Feb; 61(2):155-63. PubMed ID: 16433870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Routine measurement of fluoxetine and norfluoxetine by high-performance liquid chromatography with ultraviolet detection in patients under concomitant treatment with tricyclic antidepressants.
    Meineke I; Schreeb K; Kress I; Gundert-Remy U
    Ther Drug Monit; 1998 Feb; 20(1):14-9. PubMed ID: 9485548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine and norfluoxetine concentrations in nursing infants and breast milk.
    Hendrick V; Stowe ZN; Altshuler LL; Mintz J; Hwang S; Hostetter A; Suri R; Leight K; Fukuchi A
    Biol Psychiatry; 2001 Nov; 50(10):775-82. PubMed ID: 11720696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of norfluoxetine in rats: Increasing extracellular serotonin level in the frontal cortex.
    Qu Y; Aluisio L; Lord B; Boggs J; Hoey K; Mazur C; Lovenberg T
    Pharmacol Biochem Behav; 2009 May; 92(3):469-73. PubMed ID: 19463261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of fluoxetine and norfluoxetine serum levels by reversed-phase high-performance liquid chromatography with ultraviolet detection.
    Holladay JW; Dewey MJ; Yoo SD
    J Chromatogr B Biomed Sci Appl; 1997 Dec; 704(1-2):259-63. PubMed ID: 9518159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of fluoxetine and norfluoxetine in pregnancy and lactation.
    Heikkinen T; Ekblad U; Palo P; Laine K
    Clin Pharmacol Ther; 2003 Apr; 73(4):330-7. PubMed ID: 12709723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with fluoxetine and norfluoxetine plasma concentrations and clinical response in Mexican patients with mental disorders.
    Sagahón-Azúa J; Medellín-Garibay SE; Chávez-Castillo CE; González-Salinas CG; Milán-Segovia RDC; Romano-Moreno S
    Pharmacol Res Perspect; 2021 Oct; 9(5):e00864. PubMed ID: 34523245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum concentrations of fluoxetine in the clinical treatment setting.
    Lundmark J; Reis M; Bengtsson F
    Ther Drug Monit; 2001 Apr; 23(2):139-47. PubMed ID: 11294514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of liquid chromatography with fluorescence detection to liquid chromatography-mass spectrometry for the determination of fluoxetine and norfluoxetine in human plasma.
    Kovacevic I; Pokrajac M; Miljkovic B; Jovanovic D; Prostran M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jan; 830(2):372-6. PubMed ID: 16356789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.